Identification of mutations in the NUCB2/nesfatin gene in children with severe obesity

Molecular Genetics and Metabolism

Volumn 107, Issue 4, 2012, Pages 729-734

  Zegers, Doreen ^a   Beckers, Sigri ^a   de Freitas, Fenna ^a   Jennes, Karen ^a   Van Camp, Jasmijn K ^a   Mertens, Ilse L ^b   Van Hoorenbeeck, Kim ^b   Rooman, Raoul P ^b   Desager, Kristine N ^b   Massa, Guy ^c   Van Gaal, Luc F ^b   Van Hul, Wim ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c JESSA HOSPITAL   (Belgium)

Author keywords

Melanocortin signalling; Mutation analysis; Nesfatin; NUCB2; Obesity

Indexed keywords

MESSENGER RNA; NESFATIN 1; NEUROPEPTIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ENERGY BALANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD INTAKE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HYPOTHALAMUS; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NONSENSE MUTATION; NUCB2 GENE; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; SATIETY; WESTERN BLOTTING;

ADOLESCENT; AMINO ACID SUBSTITUTION; CALCIUM-BINDING PROTEINS; CHILD; DNA-BINDING PROTEINS; FEMALE; GENE ORDER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; NERVE TISSUE PROTEINS; OBESITY;

RODENTIA;

EID: 84869884748     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2012.10.014     Document Type: Article

References (48)

1. Hetherington A.W., Ranson S.W. Nutrition classics. The Anatomical record, volume 78, 1940: hypothalamic lesions and adiposity in the rat. Nutr. Rev. 1983, 41:124-127.
2. Elmquist J.K. Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Physiol. Behav. 2001, 74:703-708.
3. Abbott C.R., Kennedy A.R., Wren A.M., Rossi M., Murphy K.G., Seal L.J., Todd J.F., Ghatei M.A., Small C.J., Bloom S.R. Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. Endocrinology 2003, 144:3943-3949.
4. Beckers S., Zegers D., Van Gaal L.F., Van Hul W. The role of the leptin-melanocortin signalling pathway in the control of food intake. Crit. Rev. Eukaryot. Gene Expr. 2009, 19:267-287.
5. Vaisse C., Clement K., Guy-Grand B., Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 1998, 20:113-114.
6. Yeo G.S., Farooqi I.S., Aminian S., Halsall D.J., Stanhope R.G., O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 1998, 20:111-112.
7. Tao Y.X. The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr. Rev. 2010, 31:506-543.
8. Strobel A., Issad T., Camoin L., Ozata M., Strosberg A.D. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat. Genet. 1998, 18:213-215.
9. Clement K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D., Gourmelen M., Dina C., Chambaz J., Lacorte J.M., Basdevant A., Bougneres P., Lebouc Y., Froguel P., Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998, 392:398-401.
10. Krude H., Biebermann H., Luck W., Horn R., Brabant G., Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 1998, 19:155-157.
11. Jackson R.S., Creemers J.W., Ohagi S., Raffin-Sanson M.L., Sanders L., Montague C.T., Hutton J.C., O'Rahilly S. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 1997, 16:303-306.
12. Lee Y.S., Poh L.K., Loke K.Y. A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J. Clin. Endocrinol. Metab. 2002, 87:1423-1426.
13. Gray J., Yeo G.S., Cox J.J., Morton J., Adlam A.L., Keogh J.M., Yanovski J.A., El Gharbawy A., Han J.C., Tung Y.C., Hodges J.R., Raymond F.L., O'Rahilly S., Farooqi I.S. Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 2006, 55:3366-3371.
14. Yeo G.S., Connie Hung C.C., Rochford J., Keogh J., Gray J., Sivaramakrishnan S., O'Rahilly S., Farooqi I.S. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat. Neurosci. 2004, 7:1187-1189.
15. Holder J.L., Butte N.F., Zinn A.R. Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Hum. Mol. Genet. 2000, 9:101-108.
16. Oh I.S., Shimizu H., Satoh T., Okada S., Adachi S., Inoue K., Eguchi H., Yamamoto M., Imaki T., Hashimoto K., Tsuchiya T., Monden T., Horiguchi K., Yamada M., Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006, 443:709-712.
17. Barnikol-Watanabe S., Gross N.A., Gotz H., Henkel T., Karabinos A., Kratzin H., Barnikol H.U., Hilschmann N. Human protein NEFA, a novel DNA binding/EF-hand/leucine zipper protein. Molecular cloning and sequence analysis of the cDNA, isolation and characterization of the protein. Biol. Chem. Hoppe Seyler 1994, 375:497-512.
18. Shimizu H., Oh I.S., Hashimoto K., Nakata M., Yamamoto S., Yoshida N., Eguchi H., Kato I., Inoue K., Satoh T., Okada S., Yamada M., Yada T., Mori M. Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 2009, 150:662-671.
19. Stengel A., Goebel-Stengel M., Wang L., Kato I., Mori M., Tache Y. Nesfatin-1(30-59) but not the N- and C-terminal fragments, nesfatin-1(1-29) and nesfatin-1(60-82) injected intracerebroventricularly decreases dark phase food intake by increasing inter-meal intervals in mice. Peptides 2012, 35:143-148.
20. Ramanjaneya M., Chen J., Brown J.E., Tripathi G., Hallschmid M., Patel S., Kern W., Hillhouse E.W., Lehnert H., Tan B.K., Randeva H.S. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 2010, 151:3169-3180.
21. Foo K.S., Brauner H., Ostenson C.G., Broberger C. Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state. J. Endocrinol. 2010, 204:255-263.
22. Zhang A.Q., Li X.L., Jiang C.Y., Lin L., Shi R.H., Chen J.D., Oomura Y. Expression of nesfatin-1/NUCB2 in rodent digestive system. World J. Gastroenterol. 2010, 16:1735-1741.
23. Pan W., Hsuchou H., Kastin A.J. Nesfatin-1 crosses the blood-brain barrier without saturation. Peptides 2007, 28:2223-2228.
24. Price T.O., Samson W.K., Niehoff M.L., Banks W.A. Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1. Peptides 2007, 28:2372-2381.
25. Shimizu H., Oh I.S., Okada S., Mori M. Nesfatin-1: an overview and future clinical application. Endocr. J. 2009, 56:537-543.
26. Zegers D., Beckers S., Mertens I.L., Van Gaal L.F., Van Hul W. Association between polymorphisms of the Nesfatin gene, NUCB2, and obesity in men. Mol. Genet. Metab. 2011, 103:282-286.
27. Roelants M., Hauspie R., Hoppenbrouwers K. References for growth and pubertal development from birth to 21 years in Flanders, Belgium. Ann. Hum. Biol. 2009, 36:680-694.
28. Beckers S., Mertens I., Peeters A., Van Gaal L., Van Hul W. Screening for melanocortin-4 receptor mutations in a cohort of Belgian morbidly obese adults and children. Int. J. Obes. (Lond) 2006, 30:221-225.
29. Beckers S., Zegers D., de Freitas F., Peeters A.V., Verhulst S.L., Massa G., Van Gaal L.F., Timmermans J.P., Desager K.N., Van Hul W. Identification and functional characterization of novel mutations in the melanocortin-4 receptor. Obes. Facts 2010, 3:304-311.
30. Zegers D., Beckers S., de Freitas F., Peeters A.V., Mertens I.L., Verhulst S.L., Rooman R.P., Timmermans J.P., Desager K.N., Massa G., Van Gaal L.F., Van Hul W. Identification of three novel genetic variants in the melanocortin-3 receptor of obese children. Obesity (Silver Spring) 2011, 19:152-159.
31. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
32. Rogozin I.B., Milanesi L. Analysis of donor splice sites in different eukaryotic organisms. J. Mol. Evol. 1997, 45:50-59.
33. Hebsgaard S.M., Korning P.G., Tolstrup N., Engelbrecht J., Rouze P., Brunak S. Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res. 1996, 24:3439-3452.
34. Ramensky V., Bork P., Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002, 30:3894-3900.
35. Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., Bork P., Kondrashov A.S., Sunyaev S.R. A method and server for predicting damaging missense mutations. Nat. Methods 2010, 7:248-249.
36. Ng P.C., Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001, 11:863-874.
37. Calabrese R., Capriotti E., Fariselli P., Martelli P.L., Casadio R. Functional annotations improve the predictive score of human disease-related mutations in proteins. Hum. Mutat. 2009, 30:1237-1244.
38. Li B., Krishnan V.G., Mort M.E., Xin F., Kamati K.K., Cooper D.N., Mooney S.D., Radivojac P. Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics 2009, 25:2744-2750.
39. Exome Variant Server, NHLBI Exome Sequencing Project (ESP), Seattle, WA, July 12 2012. Available from: URL:. http://evs.gs.washington.edu/EVS/.
40. Stengel A., Tache Y. Minireview: nesfatin-1 - an emerging new player in the brain-gut, endocrine, and metabolic axis. Endocrinology 2011, 152:4033-4038.
41. Palasz A., Krzystanek M., Worthington J., Czajkowska B., Kostro K., Wiaderkiewicz R., Bajor G. Nesfatin-1, a unique regulatory neuropeptide of the brain. Neuropeptides 2012, 46:105-112.
42. Stengel A., Goebel M., Yakubov I., Wang L., Witcher D., Coskun T., Tache Y., Sachs G., Lambrecht N.W. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 2009, 150:232-238.
43. Gonzalez R., Tiwari A., Unniappan S. Pancreatic beta cells colocalize insulin and pronesfatin immunoreactivity in rodents. Biochem. Biophys. Res. Commun. 2009, 381:643-648.
44. Stengel A., Goebel M., Tache Y. Nesfatin-1: a novel inhibitory regulator of food intake and body weight. Obes. Rev. 2011, 12:261-271.
45. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88:131-141.
46. Michaud J.L., Boucher F., Melnyk A., Gauthier F., Goshu E., Levy E., Mitchell G.A., Himms-Hagen J., Fan C.M. Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. Hum. Mol. Genet. 2001, 10:1465-1473.
47. Nesselhut J., Jurgan U., Onken E., Gotz H., Barnikol H.U., Hirschfeld G., Barnikol-Watanabe S., Hilschmann N. Golgi retention of human protein NEFA is mediated by its N-terminal Leu/Ile-rich region. FEBS Lett. 2001, 509:469-475.
48. Miura K., Titani K., Kurosawa Y., Kanai Y. Molecular cloning of nucleobindin, a novel DNA-binding protein that contains both a signal peptide and a leucine zipper structure. Biochem. Biophys. Res. Commun. 1992, 187:375-380.